title: [Alendronate--a new drug for treatment of osteoporosis].
abstract: Bisphosphonates are new drugs in the therapy of osteoporosis. Till now, several drugs were described, among them alendronate. General features of bisphosphonates and some recent results of clinical trials are presented. The authors conclude, that alendronate is a well tolerated new treatment option reducing the risk and severity of new vertebral fractures, reducing the risk of nonvertebral fractures, and reducing the height loss.
authors.affiliation: Katedry i Kliniki Chorób Wewnetrznych i Alergologii Sl. AM w Katowicach.
authors.forename: W
authors.initials: W
authors.lastname: Pluskiewicz
authors.forename: B
authors.initials: B
authors.lastname: Drozdzowska
mesh_terms: D019386:Alendronate / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D015519:Bone Density / Q000187:drug effects; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D019386:Alendronate